Skip to search formSkip to main contentSkip to account menu

orbifloxacin

Known as: 1-Cyclopropyl-7-[(3s,5r)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
1. The pharmacokinetic aspects of orbifloxacin were studied in both healthy and naturally diseased ducks after a single… 
2009
2009
ABSTRACT The pharmacokinetics (PK) and pharmacodynamics (PD) of orbifloxacin were studied in beagle dogs after intravenous (i.v… 
2009
2009
The purpose of the current investigation is to elucidate the pharmacokinetic profiles of orbifloxacin (OBFX) in lactating ewes (n… 
2009
2009
The pharmacokinetics and pharmacodynamics of orbifloxacin were studied in six clinically healthy Hanwoo cows after intravenous (i… 
2006
2006
The purpose of this study was to determine the pharmacokinetics and physicochemical characteristics of orbifloxacin in the horse… 
2006
2006
Orbifloxacin tablets were administered orally to 23 dogs with superficial and/or deep staphylococcal pyoderma. Response to… 
2001
2001
Pharmacokinetics and distribution of orbifloxacin into body fluids and endometrium was studied in 6 mares after intragastric (IG… 
1999
1999
A simple and sensitive high-performance liquid chromatography method is developed for the determination of orbifloxacin (ORB) in… 
1998
1998
Urine samples of cats and dogs collected for 24 hr after a subcutaneous injection of orbifloxacin (OBFX) were analyzed. The…